The GBA1-related variant rs12411216 is Associated with Motor and Non-Motor Impairments and Unfavorable Progression in Parkinson’s Disease: A Five-Year Longitudinal Study
Journal of Molecular Neuroscience · 2026
DOI: 10.1007/s12031-026-02615-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Neuroscience, 2026. Verfasst von Elena Bragina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Medical Genetics, Tomsk National Research Medical Center, Tomsk, Russia. elena.bragina@medgenetics.ru. Hauptthemen laut MEDLINE: Parkinson Disease, Polymorphism, Single Nucleotide, Glucosylceramidase. Die Arbeit nennt 44 Literaturangaben. Gefördert von: The work was supported by the state assignment.
Abstract (Originalsprache)
We investigated four regulatory single-nucleotide polymorphisms (SNPs) related to genes previously implicated in the autophagy-lysosomal pathway (rs76904798 and rs6581622 ( LRRK2 ), rs356182 ( SNCA ), and rs12411216 ( GBA1 )) in order to assess their association with the clinical heterogeneity of Parkinson’s disease. In a five-year observational study, 518 patients stratified by genotype were analyzed for cognitive, neuropsychiatric, motor, and other clinical signs. The rs356182 ( SNCA ) variant showed a modest association with disease traits, including significant associations with anxiety (HAMILTON scale). Conversely, the regulatory GBA1 -related variant rs12411216 demonstrated a robust pleiotropic association with earlier disease onset, more severe motor impairment, and a broad spectrum of non-motor impairments, including anxiety, depression, impulsive-compulsive behaviors, and cognitive deficits. Longitudinal analyses revealed that patients homozygous for the rs12411216 AA genotype exhibited the most unfavorable progression across multiple domains, suggesting a faster neurocognitive decline. These findings suggest that the distinct pleiotropic effects of the GBA1 -related variant rs12411216 contribute significantly to the clinical heterogeneity of PD by shaping unfavorable motor and neuropsychiatric progression trajectories. While the longitudinal design provides new evidence for genotype-dependent patterns, further functional studies are needed to confirm the proposed mechanistic link.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Medical Genetics, Tomsk National Research Medical Center, Tomsk, Russia. elena.bragina@medgenetics.ru.
- Siberian State Medical University, Tomsk, Russia.
- Research Institute of Medical Genetics, Tomsk National Research Medical Center, Tomsk, Russia.
Förderung
- The work was supported by the state assignment
Zitieren
APA
Bragina, E., Nikitina, M., Skorikov, N., Shipulina, S., Alifirova, V., & Nazarenko, M. (2026). The GBA1-related variant rs12411216 is Associated with Motor and Non-Motor Impairments and Unfavorable Progression in Parkinson’s Disease: A Five-Year Longitudinal Study. Journal of Molecular Neuroscience. https://doi.org/10.1007/s12031-026-02615-9
Vancouver
Bragina E, Nikitina M, Skorikov N, Shipulina S, Alifirova V, Nazarenko M. The GBA1-related variant rs12411216 is Associated with Motor and Non-Motor Impairments and Unfavorable Progression in Parkinson’s Disease: A Five-Year Longitudinal Study. Journal of Molecular Neuroscience. 2026. doi:10.1007/s12031-026-02615-9
BibTeX
@article{Bragina2026,
author = {Bragina, Elena and Nikitina, Maria and Skorikov, Nikolay and Shipulina, Sofia and Alifirova, Valentina and Nazarenko, Maria},
title = {The GBA1-related variant rs12411216 is Associated with Motor and Non-Motor Impairments and Unfavorable Progression in Parkinson’s Disease: A Five-Year Longitudinal Study},
journal = {Journal of Molecular Neuroscience},
year = {2026},
doi = {10.1007/s12031-026-02615-9}
}
EUVIMED